Vimizim is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How do you pay?

How to pay the least

Given by your care team

Billed by the clinic

Vimizim is given by a doctor or nurse, not picked up at a pharmacy.

  1. Ask your care team or your plan what you’d pay before your visit.

Compare every option

Question
Brand nameVimizim
Authorized genericelosulfase alfa
Regular genericelosulfase alfa
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Vimizim?
The original
–
–

Brand nameThe maker’s card

BioMarin RareConnections Co-Pay Assistance Program

Savings card from BioMarin

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0

Sign up on biomarin-rareconnections.com 

Or call 1-866-906-6100.

In the maker’s words

“Eligible commercially insured patients may pay as little as $0 for VIMIZIM…”

From the maker’s offer on biomarin-rareconnections.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Vimizim itself, from the same company, sold without the brand name, and usually for less. For now Vimizim is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Vimizim is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

VIMIZIM is a hydrolytic lysosomal glycosaminoglycan (GAG)-specific enzyme indicated for patients with Mucopolysaccharidosis type IVA (MPS IVA; Morquio A syndrome).

Source: the FDA label for Vimizim (BioMarin Pharmaceutical Inc.), October 30, 2025. Full label on DailyMed 

Good to know